Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes.

Koga T, Torigoshi T, Motokawa S, Miyashita T, Maeda Y, Nakamura M, Komori A, Aiba Y, Uemura T, Yatsuhashi H, Ishibashi H, Eguchi K, Migita K.

FEBS Lett. 2008 Mar 5;582(5):579-85. doi: 10.1016/j.febslet.2008.01.022.

2.
4.

Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor.

Sodin-Semrl S, Spagnolo A, Mikus R, Barbaro B, Varga J, Fiore S.

Int J Immunopathol Pharmacol. 2004 May-Aug;17(2):145-56.

PMID:
15171815
5.
6.

Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes.

Migita K, Koga T, Torigoshi T, Maeda Y, Miyashita T, Izumi Y, Aiba Y, Komori A, Nakamura M, Motokawa S, Ishibashi H.

Rheumatology (Oxford). 2009 Jul;48(7):741-7. doi: 10.1093/rheumatology/kep089.

7.

Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes.

Migita K, Koga T, Torigoshi T, Motokawa S, Maeda Y, Jiuchi Y, Izumi Y, Miyashita T, Nakamura M, Komori A, Ishibashi H.

Clin Exp Immunol. 2010 Nov;162(2):244-50. doi: 10.1111/j.1365-2249.2010.04242.x.

8.

Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes.

Satomura K, Torigoshi T, Koga T, Maeda Y, Izumi Y, Jiuchi Y, Miyashita T, Yamasaki S, Kawakami A, Aiba Y, Nakamura M, Komori A, Sato J, Ishibashi H, Motokawa S, Migita K.

Mod Rheumatol. 2013 Jan;23(1):28-35. doi: 10.1007/s10165-012-0630-0.

PMID:
22447522
10.

IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response.

Rasmussen MK, Iversen L, Johansen C, Finnemann J, Olsen LS, Kragballe K, Gesser B.

Inflamm Res. 2008 Jul;57(7):329-39. doi: 10.1007/s00011-007-7220-1.

PMID:
18607537
11.

Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.

Amin MA, Mansfield PJ, Pakozdi A, Campbell PL, Ahmed S, Martinez RJ, Koch AE.

Arthritis Rheum. 2007 Jun;56(6):1787-97.

12.
13.

Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis.

Lee MS, Yoo SA, Cho CS, Suh PG, Kim WU, Ryu SH.

J Immunol. 2006 Oct 15;177(8):5585-94.

14.

PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs.

Dong Z, An F, Wu T, Zhang C, Zhang M, Zhang Y, An G, An F.

J Cell Biochem. 2011 Aug;112(8):2097-105. doi: 10.1002/jcb.23128.

PMID:
21465531
15.

Annexin-1 mediates TNF-alpha-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts.

Tagoe CE, Marjanovic N, Park JY, Chan ES, Abeles AM, Attur M, Abramson SB, Pillinger MH.

J Immunol. 2008 Aug 15;181(4):2813-20.

16.

Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.

García S, Bodaño A, Pablos JL, Gómez-Reino JJ, Conde C.

Ann Rheum Dis. 2008 May;67(5):631-7.

PMID:
17890271
17.

Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes.

Vergne-Salle P, Léger DY, Bertin P, Trèves R, Beneytout JL, Liagre B.

Cytokine. 2005 Sep 7;31(5):335-48.

PMID:
16099671
18.
19.

An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes.

Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Ishibashi H, Eguchi K.

Rheumatology (Oxford). 2005 Apr;44(4):443-8.

20.

Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway.

Mullan RH, Bresnihan B, Golden-Mason L, Markham T, O'Hara R, FitzGerald O, Veale DJ, Fearon U.

Arthritis Rheum. 2006 Jan;54(1):105-14.

Items per page

Supplemental Content

Support Center